The Journal of
Clinical Psychiatry

Depression (MDD)

Perspective November 11, 2014

The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine

Jing Zhang, MD, PhD; Mitchell V. Mathis, MD; Jenn W. Sellers, MD, PhD; George Kordzakhia, PhD; Andre J. Jackson, PhD; Antonia Dow, PhD; Peiling Yang, PhD; Linda Fossom, PhD; Hao Zhu, PhD; Hiren Patel, PharmD; Ellis F. Unger, MD; Robert J. Temple, MD

J Clin Psychiatry 2015;76(1):8-14

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40.00

Members enjoy free PDF downloads on all articles. Join today

Author Affiliations

References (1)

Purchase PDF for $40.00

Members enjoy free PDF downloads on all articles. Join today

Save

Cite

SPOTLIGHT

Balancing Psychiatric Stability and Cardiometabolic Health in Bipolar I Disorder
Dr Goldberg takes viewers through two case profiles of patients with bipolar I disorder, including assessment, diagnosis, and treatment, with a focus on cardiometabolic safety.

Image of the Cover of issue 1 2024 The Journal of Clinical Psychiatry

Read the Current Issue

Editorial

Truth: Keeping Us on Track in Scientific Publishing

Systematic Review

Predictors and Risk Factors of Treatment-Resistant Depression

Systematic Review

Systematic Review of the Effects of Cannabis and Cannabinoids in PTSD Symptoms and Symptom Clusters

Original Research

A Comparison of 3 Scales for Measuring Adolescent Depression

Original Research

Efficacy and Safety of Iloperidone in Bipolar Mania

Original Research

Decrease in Alcohol Use Disorder Symptoms With Semaglutide

View current Issue